Peking Union Medical College Pharmaceutical Factory

Peking Union Medical College Pharmaceutical Factory is a state-owned pharmaceutical enterprise affiliated with the Chinese Academy of Medical Sciences and Peking Union Medical College. Founded in 1958, the company serves as a critical platform for translating academic research into commercial medical products. It specializes in the development and manufacturing of drugs for liver diseases, cardiovascular disorders, and neurological conditions. The factory is most notably recognized for Bicyclol, an innovative hepatoprotective drug developed in-house that has achieved significant market success in China and internationally. Operating under strict GMP standards, the company maintains a robust portfolio of both innovative and generic pharmaceuticals. Its unique position within China's premier medical academic institution allows it to leverage cutting-edge research for drug discovery and clinical development.